The effects of chronic restraint stress (CRS, 2 h during 14 days) on gene expression of tyrosine hydroxylase (TH), catechol-O-methyltransferase (COMT), and glutathione peroxidase (GPx) were studied in the rat hippocampus. Changes in the dopamine (DA) concentration and activities of monoamine oxidases (MAO A and MAO B) and GPx in this cerebral structure of chronically stressed rats were also examined. The investigated parameters were quantified using real-time RT-PCR, Western blot analyses, and assay of enzymatic activity. We found that CRS decreased the TH protein level and DA concentration, which probably confirms the statement that de novo synthesis of DA is suppressed under stress conditions. The increased activities of MAO B, as well as the increased level of COMT protein, are believed to be related to intensified DA catabolism conditions. Also, a decreased activity of GPx in the hippocampus of chronically stressed animals was found. The increased enzymatic activity of MAO B negatively correlated with the reduced activity of GPx under the above-mentioned stress conditions. These events in the hippocampus of chronically stressed animals could synergistically cause oxidative damage to the mitochondria.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Y. C. Tse, I. Montoya, A. S. Wong, et al., “A longitudinal study of stress-induced hippocampal volume changes in mice that are susceptible or resilient to chronic social defeat,” Hippocampus, 24, 1120-1128 (2014).
B. S. McEwen and A. M. Magarinos, “Stress effects on morphology and function of the hippocampus,” Ann. N.Y. Acad. Sci., 821, 271-284 (1997).
Xh Li, Jx Chen, Gx Yue, et al., “Gene expression profile of the hippocampus of rats subjected to chronic immobilization stress,” PLoS One, 8, No. 3, e57621 (2013).
A. Ahmad, N. Rasheed, K. Chand, et al., “Restraint stress-induced central monoaminergic & oxidative changes in rats & their prevention by novel Ocimum sanctum compounds,” Indian J. Med. Res., 135, No. 4, 548-554 (2012).
C. Nunes, R. M. Barbosa, L. Almeida, and J. Laranjinha, “Nitric oxide and DOPAC-induced cell death: from GSH depletion to mitochondrial energy crisis,” Mol. Cell Neurosci., 48, No. 1, 94-103 (2011).
L. Gavrilovic, N. Spasojevic, and S. Dronjak, “Subsequent stress increases gene expression of catecholamine synthetic enzymes in cardiac ventricles of chronic-stressed rats,” Endocrine, 37, 425-429 (2010).
N. Popović, S. B. Pajović, V. Stojiljković, et al., “Prefrontal catecholaminergic turnover and antioxidant defense system of chronically stressed rats,” Folia Biol., 65, No. 1, 43-54 (2017).
G. D. Gamaro, M. B. Michalowski, D. H. Catelli, et al., “Effect of repeated restraint stress on memory in different tasks,” Braz. J. Med. Biol. Res., 32, No. 3, 341-347 (1999).
K. S. Kim and P. L. Han, “Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters,” J. Neurosci. Res., 83, No. 3, 497-507 (2006).
L. Gavrilović, V. Stojiljković, J. Kasapović, et al., “Treadmill exercise does not change gene expression of adrenal catecholamine biosynthetic enzymes in chronically stressed rats,” Ann. Acad. Bras. Cienc., 85, No. 3, 999-1012 (2013).
T. M. Stich, “Determination of protein covalently bound to agarose supports using bicinchoninic acid,” Ann. Biochem., 191, 343-346 (1990).
U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, 227, 680-685 (1970).
M. Zhou and N. Panchuk-Voloshina, “A one-step fluorometric method for the continuous measurement of monoamine oxidase activity,” Analyt. Biochem., 253, No. 2, 169-174 (1997).
V. Stojiljković, A. Todorović, S. Pejić, et al., “Antioxidant status and lipid peroxidation in small intestinal mucosa of children with celiac disease,” Clin. Biochem., 42, Nos. 13/14, 1431-1437 (2009).
M. Bortolato, K. Chen, and J. C. Shih, “Monoamine oxidase inactivation: from pathophysiology to therapeutics,” Adv. Drug. Deliv. Rev., 60, 1527-1533 (2008).
A. M. Cesura and A. Pletscher, “The new generation of monoamine oxidase inhibitors,” Prog. Drug. Res., 38, 171-297 (1992).
J. Knoll, “(-)Deprenyl (selegiline): past, present and future,” Neurobiology, 8, 179-199 (2000).
T. Müller, “Catechol-O-methyltransferase inhibitors in Parkinson’s disease,” Drugs, 75, No. 2, 157-174 (2015).
V. Nilakantan, X. Zhou, G. Hilton, et al., “Hierarchical change in antioxidant enzyme gene expression and activity in acute cardiac rejection: role of inducible nitric oxide synthase,” Mol. Cell Biochem., 270, Nos. 1/2, 39-47 (2005).
M. Hsu, B. Srinivas, J. Kumar, et al., “Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson’s disease,” J. Neurochem., 92, 1091-1103 (2005).
J. E. Duda, B. I. Giasson, Q. Chen, et al., “Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies,” Am. J. Pathol., 157, 1439-1445 (2000).
B. I. Giasson, J. E. Duda, I. V. Murray, et al., “Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions,” Science, 290, 985-989 (2000).
P. Klivenyi, O. A. Andreassen, R. J. Ferrante, et al., “Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity,” NeuroReport, 11, 1265-1268 (2000).
Watanabe Y, Kato H, Araki T, “Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson’s disease,” Metab. Brain Dis., 23, 51-69 (2008).
H. Yokoyama, S. Takagi, Y. Watanabe, et al., “Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice,” J. Neural Transm., 115, 831-842 (2008).
T. Alexander, C. E. Sortwell, C. D. Sladek, et al., “Comparison of neurotoxicity following repeated administration of L-dopa, D-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague–Dawley donors,” Cell Transplant., 6, 309-315 (1997).
F. Filloux and J. J. Townsend, “Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection,” Exp. Neurol., 119, 79-88 (1993).
T. G. Hastings, D. A. Lewis, and M. J. Zigmond, “Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections,” Proc. Natl. Acad. Sci. USA, 93, 1956-1961 (1996).
P. P. Michel and F. Hefti, “Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture,” J. Neurosci. Res., 26, 428-435 (1990).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Popović, N., Pajović, S.B., Stojiljković, V. et al. Activities of the Dopaminergic System and Glutathione Antioxidant System in the Hippocampus of Stressed rats. Neurophysiology 50, 332–338 (2018). https://doi.org/10.1007/s11062-019-09758-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11062-019-09758-z